Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 7.16990247 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.16990247 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.89273075 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.89273075 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.42061917 |
6 | tryptophan catabolic process (GO:0006569) | 5.74518351 |
7 | indole-containing compound catabolic process (GO:0042436) | 5.74518351 |
8 | indolalkylamine catabolic process (GO:0046218) | 5.74518351 |
9 | glyoxylate metabolic process (GO:0046487) | 5.64718128 |
10 | bile acid biosynthetic process (GO:0006699) | 5.55804941 |
11 | kynurenine metabolic process (GO:0070189) | 5.47177581 |
12 | tryptophan metabolic process (GO:0006568) | 5.41761611 |
13 | cysteine metabolic process (GO:0006534) | 5.40814592 |
14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.33959237 |
15 | complement activation, alternative pathway (GO:0006957) | 5.33812644 |
16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.32683474 |
17 | negative regulation of fibrinolysis (GO:0051918) | 5.30388544 |
18 | homocysteine metabolic process (GO:0050667) | 5.26714993 |
19 | sulfur amino acid catabolic process (GO:0000098) | 5.23914785 |
20 | urea cycle (GO:0000050) | 5.09964347 |
21 | urea metabolic process (GO:0019627) | 5.09964347 |
22 | regulation of protein activation cascade (GO:2000257) | 5.06319196 |
23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.96995714 |
24 | drug catabolic process (GO:0042737) | 4.96583101 |
25 | behavioral response to nicotine (GO:0035095) | 4.95650265 |
26 | lysine catabolic process (GO:0006554) | 4.92502811 |
27 | lysine metabolic process (GO:0006553) | 4.92502811 |
28 | regulation of fibrinolysis (GO:0051917) | 4.92083503 |
29 | protein carboxylation (GO:0018214) | 4.91281375 |
30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.91281375 |
31 | regulation of complement activation (GO:0030449) | 4.84948876 |
32 | serine family amino acid catabolic process (GO:0009071) | 4.80940546 |
33 | high-density lipoprotein particle remodeling (GO:0034375) | 4.76322976 |
34 | exogenous drug catabolic process (GO:0042738) | 4.74400917 |
35 | nitrogen cycle metabolic process (GO:0071941) | 4.70315655 |
36 | bile acid metabolic process (GO:0008206) | 4.66260415 |
37 | aromatic amino acid family metabolic process (GO:0009072) | 4.63613391 |
38 | ethanol oxidation (GO:0006069) | 4.55155618 |
39 | amino-acid betaine metabolic process (GO:0006577) | 4.46832827 |
40 | tyrosine metabolic process (GO:0006570) | 4.41829480 |
41 | alpha-amino acid catabolic process (GO:1901606) | 4.41459715 |
42 | urate metabolic process (GO:0046415) | 4.26920750 |
43 | cellular ketone body metabolic process (GO:0046950) | 4.25557941 |
44 | regulation of triglyceride catabolic process (GO:0010896) | 4.22700115 |
45 | drug metabolic process (GO:0017144) | 4.19251782 |
46 | L-fucose catabolic process (GO:0042355) | 4.15394819 |
47 | fucose catabolic process (GO:0019317) | 4.15394819 |
48 | L-fucose metabolic process (GO:0042354) | 4.15394819 |
49 | benzene-containing compound metabolic process (GO:0042537) | 4.14321505 |
50 | cellular amino acid catabolic process (GO:0009063) | 4.11665186 |
51 | drug transmembrane transport (GO:0006855) | 4.08943162 |
52 | reverse cholesterol transport (GO:0043691) | 4.08755370 |
53 | regulation of cholesterol esterification (GO:0010872) | 4.05512890 |
54 | acylglycerol homeostasis (GO:0055090) | 4.04724698 |
55 | triglyceride homeostasis (GO:0070328) | 4.04724698 |
56 | negative regulation of cholesterol transport (GO:0032375) | 4.04449739 |
57 | negative regulation of sterol transport (GO:0032372) | 4.04449739 |
58 | protein-lipid complex remodeling (GO:0034368) | 4.03951216 |
59 | macromolecular complex remodeling (GO:0034367) | 4.03951216 |
60 | plasma lipoprotein particle remodeling (GO:0034369) | 4.03951216 |
61 | coenzyme catabolic process (GO:0009109) | 4.03388648 |
62 | indolalkylamine metabolic process (GO:0006586) | 4.02810049 |
63 | cellular glucuronidation (GO:0052695) | 4.01905016 |
64 | cellular modified amino acid catabolic process (GO:0042219) | 4.00124969 |
65 | glutamate metabolic process (GO:0006536) | 3.97891302 |
66 | aldehyde catabolic process (GO:0046185) | 3.97591703 |
67 | serine family amino acid metabolic process (GO:0009069) | 3.96398206 |
68 | bile acid and bile salt transport (GO:0015721) | 3.95608574 |
69 | plasma lipoprotein particle clearance (GO:0034381) | 3.93562569 |
70 | amine catabolic process (GO:0009310) | 3.90189511 |
71 | cellular biogenic amine catabolic process (GO:0042402) | 3.90189511 |
72 | epoxygenase P450 pathway (GO:0019373) | 3.88877205 |
73 | short-chain fatty acid metabolic process (GO:0046459) | 3.88095777 |
74 | imidazole-containing compound metabolic process (GO:0052803) | 3.85071494 |
75 | glycine metabolic process (GO:0006544) | 3.84067415 |
76 | phospholipid efflux (GO:0033700) | 3.75876741 |
77 | acetyl-CoA metabolic process (GO:0006084) | 3.71315694 |
78 | arginine metabolic process (GO:0006525) | 3.70918731 |
79 | cholesterol efflux (GO:0033344) | 3.69025207 |
80 | fibrinolysis (GO:0042730) | 3.68353560 |
81 | flavonoid metabolic process (GO:0009812) | 3.68204706 |
82 | carboxylic acid catabolic process (GO:0046395) | 3.67385768 |
83 | organic acid catabolic process (GO:0016054) | 3.67385768 |
84 | uronic acid metabolic process (GO:0006063) | 3.66789715 |
85 | glucuronate metabolic process (GO:0019585) | 3.66789715 |
86 | ketone body metabolic process (GO:1902224) | 3.66605830 |
87 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.65150498 |
88 | regulation of cholesterol homeostasis (GO:2000188) | 3.62287848 |
89 | regulation of bile acid biosynthetic process (GO:0070857) | 3.60002661 |
90 | serine family amino acid biosynthetic process (GO:0009070) | 3.57135218 |
91 | fatty acid beta-oxidation (GO:0006635) | 3.56308129 |
92 | complement activation, classical pathway (GO:0006958) | 3.55790869 |
93 | fatty acid oxidation (GO:0019395) | 3.54052127 |
94 | response to nitrosative stress (GO:0051409) | 3.53413245 |
95 | aspartate family amino acid catabolic process (GO:0009068) | 3.53300293 |
96 | complement activation (GO:0006956) | 3.52441780 |
97 | cytolysis (GO:0019835) | 3.51522991 |
98 | monocarboxylic acid catabolic process (GO:0072329) | 3.49580558 |
99 | ethanol metabolic process (GO:0006067) | 3.48498427 |
100 | cholesterol homeostasis (GO:0042632) | 3.48231767 |
101 | regulation of hippo signaling (GO:0035330) | 3.48126358 |
102 | lipid oxidation (GO:0034440) | 3.46981057 |
103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.44563053 |
104 | sterol homeostasis (GO:0055092) | 3.44020980 |
105 | cofactor catabolic process (GO:0051187) | 3.40055556 |
106 | toxin metabolic process (GO:0009404) | 3.29058351 |
107 | neuronal action potential (GO:0019228) | 3.09414076 |
108 | nephron epithelium morphogenesis (GO:0072088) | 3.06590598 |
109 | nephron tubule morphogenesis (GO:0072078) | 3.06590598 |
110 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.01668700 |
111 | response to pheromone (GO:0019236) | 3.01548240 |
112 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.00585178 |
113 | sulfation (GO:0051923) | 2.98565427 |
114 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.97103081 |
115 | dopamine transport (GO:0015872) | 2.96144544 |
116 | surfactant homeostasis (GO:0043129) | 2.95778872 |
117 | platelet dense granule organization (GO:0060155) | 2.94894380 |
118 | indole-containing compound metabolic process (GO:0042430) | 2.90615009 |
119 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.89043953 |
120 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.87540887 |
121 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.86162639 |
122 | regulation of endothelial cell differentiation (GO:0045601) | 2.84191174 |
123 | chemical homeostasis within a tissue (GO:0048875) | 2.76053698 |
124 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.74801023 |
125 | detection of light stimulus involved in visual perception (GO:0050908) | 2.74801023 |
126 | negative regulation of mast cell activation (GO:0033004) | 2.74420235 |
127 | renal tubule morphogenesis (GO:0061333) | 2.72282204 |
128 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.71189077 |
129 | gamma-aminobutyric acid transport (GO:0015812) | 2.70964650 |
130 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.69080796 |
131 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.65496697 |
132 | positive regulation of digestive system process (GO:0060456) | 2.63314268 |
133 | primary amino compound metabolic process (GO:1901160) | 2.60066112 |
134 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.59151950 |
135 | lymphangiogenesis (GO:0001946) | 2.58726440 |
136 | DNA deamination (GO:0045006) | 2.58168917 |
137 | serotonin metabolic process (GO:0042428) | 2.55241516 |
138 | reflex (GO:0060004) | 2.55041306 |
139 | behavioral response to ethanol (GO:0048149) | 2.52338412 |
140 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.51062985 |
141 | regulation of action potential (GO:0098900) | 2.50540989 |
142 | nucleobase catabolic process (GO:0046113) | 2.48615557 |
143 | positive regulation of fatty acid transport (GO:2000193) | 2.48070916 |
144 | transepithelial transport (GO:0070633) | 2.47893083 |
145 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.46726360 |
146 | neurotransmitter metabolic process (GO:0042133) | 2.45760055 |
147 | membrane depolarization during action potential (GO:0086010) | 2.42515340 |
148 | epithelial cilium movement (GO:0003351) | 2.41894363 |
149 | auditory receptor cell stereocilium organization (GO:0060088) | 2.39727688 |
150 | atrial cardiac muscle cell action potential (GO:0086014) | 2.38911217 |
151 | positive regulation of action potential (GO:0045760) | 2.38390292 |
152 | inner ear receptor stereocilium organization (GO:0060122) | 2.37977787 |
153 | dopamine biosynthetic process (GO:0042416) | 2.37302138 |
154 | negative regulation of telomere maintenance (GO:0032205) | 2.35276052 |
155 | kidney morphogenesis (GO:0060993) | 2.34575606 |
156 | action potential (GO:0001508) | 2.34167202 |
157 | cAMP catabolic process (GO:0006198) | 2.33494737 |
158 | thyroid hormone metabolic process (GO:0042403) | 2.31307488 |
159 | smooth muscle tissue development (GO:0048745) | 2.31195444 |
160 | regulation of mesoderm development (GO:2000380) | 2.30158649 |
161 | synaptic transmission, cholinergic (GO:0007271) | 2.28792931 |
162 | one-carbon compound transport (GO:0019755) | 2.28658357 |
163 | nonmotile primary cilium assembly (GO:0035058) | 2.27966515 |
164 | axoneme assembly (GO:0035082) | 2.25781580 |
165 | norepinephrine metabolic process (GO:0042415) | 2.23740540 |
166 | cilium movement (GO:0003341) | 2.22312547 |
167 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.22072574 |
168 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.21444798 |
169 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.20878662 |
170 | NADH dehydrogenase complex assembly (GO:0010257) | 2.20878662 |
171 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.20878662 |
172 | cyclic nucleotide catabolic process (GO:0009214) | 2.19989312 |
173 | protein complex biogenesis (GO:0070271) | 2.19473363 |
174 | parturition (GO:0007567) | 2.18356727 |
175 | rhodopsin mediated signaling pathway (GO:0016056) | 2.16491233 |
176 | regulation of gene silencing by RNA (GO:0060966) | 2.16251112 |
177 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.16251112 |
178 | regulation of gene silencing by miRNA (GO:0060964) | 2.16251112 |
179 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.15780003 |
180 | sulfate transmembrane transport (GO:1902358) | 2.14735626 |
181 | protein polyglutamylation (GO:0018095) | 2.14615254 |
182 | fucosylation (GO:0036065) | 2.13429595 |
183 | regulation of membrane repolarization (GO:0060306) | 2.12832938 |
184 | somite development (GO:0061053) | 2.12634871 |
185 | neuron maturation (GO:0042551) | 2.12352938 |
186 | positive regulation of icosanoid secretion (GO:0032305) | 2.12111513 |
Rank | Gene Set | Z-score |
---|---|---|
1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.69581533 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.57632227 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.12049426 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.06838370 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.40537670 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.74236490 |
7 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.37156499 |
8 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.91534577 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.77320550 |
10 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.64860104 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.48845825 |
12 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.06926172 |
13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.94959983 |
14 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.94249317 |
15 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.47273974 |
16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.34029118 |
17 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.27633159 |
18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09598046 |
19 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.7983936 |
20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.95829443 |
21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94260523 |
22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.94246318 |
23 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.92210153 |
24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.89404801 |
25 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85416285 |
26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.85361890 |
27 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.83635672 |
28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.76724435 |
29 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.72661287 |
30 | P300_19829295_ChIP-Seq_ESCs_Human | 1.72609464 |
31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72385958 |
32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.66174821 |
33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.64659678 |
34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64651328 |
35 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.63036173 |
36 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.60270159 |
37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59778983 |
38 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.59722724 |
39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57730330 |
40 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.55461010 |
41 | EWS_26573619_Chip-Seq_HEK293_Human | 1.53453428 |
42 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.51316496 |
43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50245642 |
44 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49911347 |
45 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.49795234 |
46 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47838561 |
47 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.46583455 |
48 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.46328972 |
49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45486280 |
50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43562490 |
51 | STAT3_23295773_ChIP-Seq_U87_Human | 1.43237861 |
52 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.42702928 |
53 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.41135502 |
54 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.39425637 |
55 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36772515 |
56 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36517326 |
57 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34956149 |
58 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.33776766 |
59 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.33410265 |
60 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.32882467 |
61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.32767018 |
62 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.32128342 |
63 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.30824804 |
64 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.29595789 |
65 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29520248 |
66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28997217 |
67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.28851451 |
68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.28109673 |
69 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.26616531 |
70 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26422101 |
71 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.26290726 |
72 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25806118 |
73 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.25031049 |
74 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.21652990 |
75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21259820 |
76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21009218 |
77 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.20475881 |
78 | * GATA1_22025678_ChIP-Seq_K562_Human | 1.20104052 |
79 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.20066318 |
80 | TP53_16413492_ChIP-PET_HCT116_Human | 1.19905032 |
81 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18709807 |
82 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17227582 |
83 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.17053160 |
84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16158495 |
85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16116160 |
86 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.16090949 |
87 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15432721 |
88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.15170725 |
89 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14715171 |
90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14715171 |
91 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.14645089 |
92 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.14645089 |
93 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14480539 |
94 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.14480539 |
95 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.14350418 |
96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14250094 |
97 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13858059 |
98 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.13856776 |
99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13451259 |
100 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13329217 |
101 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.12692825 |
102 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12464513 |
103 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.12229755 |
104 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.12191848 |
105 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.11565714 |
106 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.11565714 |
107 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.10888882 |
108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09856292 |
109 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09608295 |
110 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09608295 |
111 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.09556979 |
112 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.08314147 |
113 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07389757 |
114 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.07327697 |
115 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06320344 |
116 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04196641 |
117 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04103103 |
118 | * GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.03707279 |
119 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03208868 |
120 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02311177 |
121 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.02065949 |
122 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.00626566 |
123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.00616281 |
124 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00148378 |
125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00119127 |
126 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99508496 |
127 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99305976 |
128 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98416077 |
129 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.97764132 |
130 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.96879363 |
131 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95058221 |
132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.93694450 |
133 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91212387 |
134 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90815008 |
135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88010601 |
136 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85766582 |
137 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85766582 |
138 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.82596083 |
139 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81601114 |
140 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.81326073 |
141 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.80486143 |
142 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80168824 |
143 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.76968049 |
144 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.76814700 |
145 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76425889 |
146 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.75862839 |
147 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.74556853 |
148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73196821 |
149 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72945206 |
150 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.72726689 |
151 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.70121989 |
152 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.67506732 |
153 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.67261315 |
154 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.64465087 |
155 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.64168298 |
156 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63861334 |
157 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63167604 |
158 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.62843856 |
159 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.62843856 |
160 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.62591727 |
161 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.62452242 |
162 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.62112893 |
163 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.61791988 |
164 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.60923558 |
165 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.59827384 |
166 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.57912414 |
167 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.57770191 |
168 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.57704437 |
169 | GATA2_19941826_ChIP-Seq_K562_Human | 0.56718714 |
170 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.56088705 |
171 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.55831745 |
172 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.55513668 |
173 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.55090585 |
174 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54801059 |
175 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53611830 |
176 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.52649783 |
177 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.52643029 |
178 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52380812 |
179 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52364229 |
180 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.51605266 |
181 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51277264 |
182 | * MYC_19915707_ChIP-ChIP_AK7_Human | 0.50844165 |
183 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.50840714 |
184 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50774028 |
185 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.50747641 |
186 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49577091 |
187 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.49138189 |
188 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.49011340 |
189 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.46748683 |
190 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.46122166 |
191 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46031032 |
192 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.45700712 |
193 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44958767 |
194 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.44651588 |
195 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.43982550 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.94451914 |
2 | MP0005360_urolithiasis | 7.23013404 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.81759387 |
4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.56834565 |
5 | MP0005365_abnormal_bile_salt | 5.55983372 |
6 | MP0003252_abnormal_bile_duct | 3.65429817 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.57501314 |
8 | MP0010329_abnormal_lipoprotein_level | 3.24789711 |
9 | MP0002138_abnormal_hepatobiliary_system | 3.18045874 |
10 | MP0005083_abnormal_biliary_tract | 3.00850425 |
11 | MP0005332_abnormal_amino_acid | 2.90785973 |
12 | MP0009840_abnormal_foam_cell | 2.73360239 |
13 | MP0003191_abnormal_cellular_cholesterol | 2.49440293 |
14 | MP0003195_calcinosis | 2.46885252 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.43032067 |
16 | MP0001666_abnormal_nutrient_absorption | 2.29932288 |
17 | MP0005551_abnormal_eye_electrophysiolog | 2.26051689 |
18 | MP0003136_yellow_coat_color | 2.20596857 |
19 | MP0005503_abnormal_tendon_morphology | 2.16297834 |
20 | MP0003283_abnormal_digestive_organ | 2.12856969 |
21 | MP0001986_abnormal_taste_sensitivity | 2.09206435 |
22 | MP0002118_abnormal_lipid_homeostasis | 1.99005268 |
23 | MP0002102_abnormal_ear_morphology | 1.96926566 |
24 | MP0000609_abnormal_liver_physiology | 1.92623671 |
25 | MP0002638_abnormal_pupillary_reflex | 1.90434843 |
26 | MP0003646_muscle_fatigue | 1.82764099 |
27 | MP0004782_abnormal_surfactant_physiolog | 1.79815428 |
28 | MP0010368_abnormal_lymphatic_system | 1.79108877 |
29 | MP0009046_muscle_twitch | 1.76839124 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.76415311 |
31 | MP0001485_abnormal_pinna_reflex | 1.74529029 |
32 | MP0006276_abnormal_autonomic_nervous | 1.71922210 |
33 | MP0005377_hearing/vestibular/ear_phenot | 1.67733245 |
34 | MP0003878_abnormal_ear_physiology | 1.67733245 |
35 | MP0004145_abnormal_muscle_electrophysio | 1.65566256 |
36 | MP0001501_abnormal_sleep_pattern | 1.64687198 |
37 | MP0004133_heterotaxia | 1.64039663 |
38 | MP0002653_abnormal_ependyma_morphology | 1.64008209 |
39 | MP0009643_abnormal_urine_homeostasis | 1.63461818 |
40 | MP0004142_abnormal_muscle_tone | 1.59422402 |
41 | MP0005171_absent_coat_pigmentation | 1.56426688 |
42 | MP0003868_abnormal_feces_composition | 1.55528264 |
43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.54094471 |
44 | MP0006072_abnormal_retinal_apoptosis | 1.52967833 |
45 | MP0001968_abnormal_touch/_nociception | 1.51884873 |
46 | MP0002272_abnormal_nervous_system | 1.51315014 |
47 | MP0009745_abnormal_behavioral_response | 1.48844958 |
48 | MP0001764_abnormal_homeostasis | 1.47316369 |
49 | MP0005253_abnormal_eye_physiology | 1.45833207 |
50 | MP0004215_abnormal_myocardial_fiber | 1.43866210 |
51 | MP0008872_abnormal_physiological_respon | 1.43211228 |
52 | MP0000631_abnormal_neuroendocrine_gland | 1.40757190 |
53 | MP0003137_abnormal_impulse_conducting | 1.39087234 |
54 | MP0003186_abnormal_redox_activity | 1.37829363 |
55 | MP0004085_abnormal_heartbeat | 1.34922225 |
56 | MP0002733_abnormal_thermal_nociception | 1.34433735 |
57 | MP0004885_abnormal_endolymph | 1.34167266 |
58 | MP0008775_abnormal_heart_ventricle | 1.32392987 |
59 | MP0003705_abnormal_hypodermis_morpholog | 1.29668895 |
60 | MP0002736_abnormal_nociception_after | 1.23014544 |
61 | MP0001905_abnormal_dopamine_level | 1.20537397 |
62 | MP0009764_decreased_sensitivity_to | 1.20354229 |
63 | MP0010386_abnormal_urinary_bladder | 1.18694611 |
64 | MP0005636_abnormal_mineral_homeostasis | 1.14320653 |
65 | MP0003724_increased_susceptibility_to | 1.14151123 |
66 | MP0002557_abnormal_social/conspecific_i | 1.11758390 |
67 | MP0000569_abnormal_digit_pigmentation | 1.08043669 |
68 | MP0005451_abnormal_body_composition | 1.07995730 |
69 | MP0001958_emphysema | 1.07405418 |
70 | MP0001440_abnormal_grooming_behavior | 1.06900113 |
71 | MP0001970_abnormal_pain_threshold | 1.06555434 |
72 | MP0003011_delayed_dark_adaptation | 1.06389681 |
73 | MP0001984_abnormal_olfaction | 1.06147691 |
74 | MP0000598_abnormal_liver_morphology | 1.06072921 |
75 | MP0002064_seizures | 1.05838034 |
76 | MP0002909_abnormal_adrenal_gland | 1.04580297 |
77 | MP0002938_white_spotting | 1.03234329 |
78 | MP0009780_abnormal_chondrocyte_physiolo | 1.03183111 |
79 | MP0003950_abnormal_plasma_membrane | 1.02494095 |
80 | MP0005167_abnormal_blood-brain_barrier | 1.02237054 |
81 | MP0009697_abnormal_copulation | 1.00528729 |
82 | MP0001486_abnormal_startle_reflex | 1.00109929 |
83 | MP0002572_abnormal_emotion/affect_behav | 1.00048943 |
84 | MP0000026_abnormal_inner_ear | 0.99321507 |
85 | MP0005647_abnormal_sex_gland | 0.98829651 |
86 | MP0001756_abnormal_urination | 0.98819043 |
87 | MP0000372_irregular_coat_pigmentation | 0.96629306 |
88 | MP0000383_abnormal_hair_follicle | 0.96617522 |
89 | MP0005620_abnormal_muscle_contractility | 0.96520442 |
90 | MP0005195_abnormal_posterior_eye | 0.95817141 |
91 | MP0002133_abnormal_respiratory_system | 0.95519268 |
92 | MP0005388_respiratory_system_phenotype | 0.95519268 |
93 | MP0005408_hypopigmentation | 0.95435995 |
94 | MP0001542_abnormal_bone_strength | 0.95235238 |
95 | MP0004742_abnormal_vestibular_system | 0.94335472 |
96 | MP0005646_abnormal_pituitary_gland | 0.93951173 |
97 | MP0002067_abnormal_sensory_capabilities | 0.93948429 |
98 | MP0001502_abnormal_circadian_rhythm | 0.93419321 |
99 | MP0009763_increased_sensitivity_to | 0.91987644 |
100 | MP0000427_abnormal_hair_cycle | 0.91542693 |
101 | MP0000604_amyloidosis | 0.91158899 |
102 | MP0000013_abnormal_adipose_tissue | 0.90407153 |
103 | MP0008877_abnormal_DNA_methylation | 0.90223328 |
104 | MP0004084_abnormal_cardiac_muscle | 0.89923385 |
105 | MP0002735_abnormal_chemical_nociception | 0.89048843 |
106 | MP0003656_abnormal_erythrocyte_physiolo | 0.88314637 |
107 | MP0008469_abnormal_protein_level | 0.88087850 |
108 | MP0003119_abnormal_digestive_system | 0.86269808 |
109 | MP0005084_abnormal_gallbladder_morpholo | 0.86247236 |
110 | MP0002933_joint_inflammation | 0.86047446 |
111 | MP0004147_increased_porphyrin_level | 0.84355714 |
112 | MP0005410_abnormal_fertilization | 0.83816304 |
113 | MP0002136_abnormal_kidney_physiology | 0.83581555 |
114 | MP0005386_behavior/neurological_phenoty | 0.83388624 |
115 | MP0004924_abnormal_behavior | 0.83388624 |
116 | MP0009642_abnormal_blood_homeostasis | 0.83075474 |
117 | MP0002132_abnormal_respiratory_system | 0.81650795 |
118 | MP0008438_abnormal_cutaneous_collagen | 0.81194671 |
119 | MP0001879_abnormal_lymphatic_vessel | 0.81172265 |
120 | MP0004130_abnormal_muscle_cell | 0.80518466 |
121 | MP0002160_abnormal_reproductive_system | 0.79869491 |
122 | MP0003879_abnormal_hair_cell | 0.78999623 |
123 | MP0005670_abnormal_white_adipose | 0.78322694 |
124 | MP0006036_abnormal_mitochondrial_physio | 0.77653626 |
125 | MP0005376_homeostasis/metabolism_phenot | 0.76723730 |
126 | MP0002254_reproductive_system_inflammat | 0.73446565 |
127 | MP0009765_abnormal_xenobiotic_induced | 0.71103445 |
128 | MP0005058_abnormal_lysosome_morphology | 0.69342680 |
129 | MP0002876_abnormal_thyroid_physiology | 0.68116447 |
130 | MP0004043_abnormal_pH_regulation | 0.66816013 |
131 | MP0005220_abnormal_exocrine_pancreas | 0.65910321 |
132 | MP0002078_abnormal_glucose_homeostasis | 0.65306244 |
133 | MP0002971_abnormal_brown_adipose | 0.64894075 |
134 | MP0001765_abnormal_ion_homeostasis | 0.64330501 |
135 | MP0003075_altered_response_to | 0.62339785 |
136 | MP0001661_extended_life_span | 0.61440874 |
137 | MP0003329_amyloid_beta_deposits | 0.61389363 |
138 | MP0003690_abnormal_glial_cell | 0.60783104 |
139 | MP0003638_abnormal_response/metabolism_ | 0.60495650 |
140 | MP0005535_abnormal_body_temperature | 0.60245343 |
141 | MP0005334_abnormal_fat_pad | 0.60240214 |
142 | MP0002168_other_aberrant_phenotype | 0.60197934 |
143 | MP0000249_abnormal_blood_vessel | 0.59504096 |
144 | MP0002295_abnormal_pulmonary_circulatio | 0.59320860 |
145 | MP0000230_abnormal_systemic_arterial | 0.53715398 |
146 | MP0005595_abnormal_vascular_smooth | 0.51938309 |
147 | MP0005395_other_phenotype | 0.51833400 |
148 | MP0005166_decreased_susceptibility_to | 0.51741705 |
149 | MP0005266_abnormal_metabolism | 0.51544399 |
150 | MP0005464_abnormal_platelet_physiology | 0.51127157 |
151 | MP0009053_abnormal_anal_canal | 0.50448488 |
152 | MP0005164_abnormal_response_to | 0.48220888 |
153 | MP0002796_impaired_skin_barrier | 0.46055923 |
154 | MP0002928_abnormal_bile_duct | 0.45493817 |
155 | MP0004883_abnormal_blood_vessel | 0.45319558 |
156 | MP0002837_dystrophic_cardiac_calcinosis | 0.44257950 |
157 | MP0005666_abnormal_adipose_tissue | 0.43781206 |
158 | MP0002135_abnormal_kidney_morphology | 0.43471693 |
159 | MP0009384_cardiac_valve_regurgitation | 0.43200766 |
160 | MP0000639_abnormal_adrenal_gland | 0.43141245 |
161 | MP0008874_decreased_physiological_sensi | 0.41690962 |
162 | MP0008873_increased_physiological_sensi | 0.40645073 |
163 | MP0005165_increased_susceptibility_to | 0.39166734 |
164 | MP0003300_gastrointestinal_ulcer | 0.38327932 |
165 | MP0005448_abnormal_energy_balance | 0.35144284 |
166 | MP0010234_abnormal_vibrissa_follicle | 0.33888340 |
167 | MP0003953_abnormal_hormone_level | 0.33548786 |
168 | MP0000343_altered_response_to | 0.33346184 |
169 | MP0001177_atelectasis | 0.32811882 |
170 | MP0005248_abnormal_Harderian_gland | 0.31902859 |
171 | MP0005275_abnormal_skin_tensile | 0.31777718 |
172 | MP0001845_abnormal_inflammatory_respons | 0.31444073 |
173 | MP0008995_early_reproductive_senescence | 0.31257213 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.10002720 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.75072690 |
3 | Intrahepatic cholestasis (HP:0001406) | 6.51694075 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.99456814 |
5 | Xanthomatosis (HP:0000991) | 5.74656758 |
6 | Prolonged partial thromboplastin time (HP:0003645) | 5.38386834 |
7 | Hypobetalipoproteinemia (HP:0003563) | 5.34018165 |
8 | Complement deficiency (HP:0004431) | 5.26560561 |
9 | Hyperlipoproteinemia (HP:0010980) | 4.84685487 |
10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.42694590 |
11 | Hyperammonemia (HP:0001987) | 4.30669632 |
12 | Joint hemorrhage (HP:0005261) | 4.30161584 |
13 | Ketosis (HP:0001946) | 4.20202514 |
14 | Hyperglycinuria (HP:0003108) | 4.18365837 |
15 | Pancreatic cysts (HP:0001737) | 4.15765200 |
16 | Hyperglycinemia (HP:0002154) | 4.08550734 |
17 | Molar tooth sign on MRI (HP:0002419) | 4.08060188 |
18 | Abnormality of midbrain morphology (HP:0002418) | 4.08060188 |
19 | Hypolipoproteinemia (HP:0010981) | 3.99522967 |
20 | Epidermoid cyst (HP:0200040) | 3.98740100 |
21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.97774552 |
22 | Abnormality of glycine metabolism (HP:0010895) | 3.97774552 |
23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.97178561 |
24 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.92323104 |
25 | Abnormality of complement system (HP:0005339) | 3.79177773 |
26 | Abnormality of the common coagulation pathway (HP:0010990) | 3.77545248 |
27 | Abnormality of methionine metabolism (HP:0010901) | 3.73714686 |
28 | Congenital stationary night blindness (HP:0007642) | 3.73598810 |
29 | Gout (HP:0001997) | 3.72016554 |
30 | Fat malabsorption (HP:0002630) | 3.70374940 |
31 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.68506938 |
32 | Nephronophthisis (HP:0000090) | 3.63495247 |
33 | Pancreatic fibrosis (HP:0100732) | 3.55632707 |
34 | Decreased circulating renin level (HP:0003351) | 3.54613314 |
35 | True hermaphroditism (HP:0010459) | 3.54559293 |
36 | Hypoalphalipoproteinemia (HP:0003233) | 3.52748223 |
37 | Hypoglycemic coma (HP:0001325) | 3.51689238 |
38 | Type II lissencephaly (HP:0007260) | 3.40726927 |
39 | Abnormality of the intrinsic pathway (HP:0010989) | 3.39026496 |
40 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.33593772 |
41 | Abnormality of purine metabolism (HP:0004352) | 3.30450890 |
42 | Abnormality of nucleobase metabolism (HP:0010932) | 3.28358971 |
43 | Abnormality of the renal cortex (HP:0011035) | 3.27025141 |
44 | Large for gestational age (HP:0001520) | 3.24850010 |
45 | Ketoacidosis (HP:0001993) | 3.24749610 |
46 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.24175135 |
47 | Hyperventilation (HP:0002883) | 3.23004015 |
48 | Abnormality of the renal medulla (HP:0100957) | 3.22731290 |
49 | Hypercholesterolemia (HP:0003124) | 3.18770917 |
50 | Keratoconus (HP:0000563) | 3.18581031 |
51 | Increased corneal curvature (HP:0100692) | 3.18581031 |
52 | Congenital, generalized hypertrichosis (HP:0004540) | 3.16540965 |
53 | Delayed CNS myelination (HP:0002188) | 3.13536808 |
54 | Tubular atrophy (HP:0000092) | 3.12913435 |
55 | Conjugated hyperbilirubinemia (HP:0002908) | 3.09371369 |
56 | Hypothermia (HP:0002045) | 3.08017697 |
57 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.05624125 |
58 | Vascular calcification (HP:0004934) | 3.00196743 |
59 | Hyperbilirubinemia (HP:0002904) | 2.94192048 |
60 | Polycythemia (HP:0001901) | 2.91850165 |
61 | Esophageal varix (HP:0002040) | 2.91656681 |
62 | Metabolic acidosis (HP:0001942) | 2.86904805 |
63 | Hepatocellular carcinoma (HP:0001402) | 2.83631720 |
64 | Steatorrhea (HP:0002570) | 2.82935179 |
65 | Systemic lupus erythematosus (HP:0002725) | 2.82667756 |
66 | Tubulointerstitial fibrosis (HP:0005576) | 2.80113871 |
67 | Thyroid-stimulating hormone excess (HP:0002925) | 2.77794182 |
68 | Abnormality of serum amino acid levels (HP:0003112) | 2.76042230 |
69 | Abolished electroretinogram (ERG) (HP:0000550) | 2.72106587 |
70 | Cardiovascular calcification (HP:0011915) | 2.70665987 |
71 | Chronic hepatic failure (HP:0100626) | 2.67836935 |
72 | Mitral stenosis (HP:0001718) | 2.65948059 |
73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.65531521 |
74 | Hyperactive renin-angiotensin system (HP:0000841) | 2.63030501 |
75 | Skin nodule (HP:0200036) | 2.61595177 |
76 | Cystic liver disease (HP:0006706) | 2.61568074 |
77 | Inability to walk (HP:0002540) | 2.60614890 |
78 | Alkalosis (HP:0001948) | 2.59663501 |
79 | Attenuation of retinal blood vessels (HP:0007843) | 2.59404269 |
80 | Myocardial infarction (HP:0001658) | 2.58482485 |
81 | Dicarboxylic aciduria (HP:0003215) | 2.54248096 |
82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.54248096 |
83 | Spastic diplegia (HP:0001264) | 2.52343441 |
84 | Medial flaring of the eyebrow (HP:0010747) | 2.50627218 |
85 | Spontaneous abortion (HP:0005268) | 2.49539052 |
86 | Lethargy (HP:0001254) | 2.47276874 |
87 | Absent/shortened dynein arms (HP:0200106) | 2.47181951 |
88 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.47181951 |
89 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.47122892 |
90 | Hyperuricemia (HP:0002149) | 2.43272455 |
91 | Increased purine levels (HP:0004368) | 2.43272455 |
92 | Abnormal drinking behavior (HP:0030082) | 2.39733385 |
93 | Polydipsia (HP:0001959) | 2.39733385 |
94 | Hyperalaninemia (HP:0003348) | 2.39675171 |
95 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.39675171 |
96 | Abnormality of alanine metabolism (HP:0010916) | 2.39675171 |
97 | Cerebellar dysplasia (HP:0007033) | 2.39148287 |
98 | Amyloidosis (HP:0011034) | 2.38532775 |
99 | Generalized aminoaciduria (HP:0002909) | 2.34230344 |
100 | Hypochromic microcytic anemia (HP:0004840) | 2.32979240 |
101 | Congenital sensorineural hearing impairment (HP:0008527) | 2.32970592 |
102 | Abnormal ciliary motility (HP:0012262) | 2.32813266 |
103 | Mesangial abnormality (HP:0001966) | 2.32788702 |
104 | Pendular nystagmus (HP:0012043) | 2.32389439 |
105 | Malnutrition (HP:0004395) | 2.31984625 |
106 | Ulnar claw (HP:0001178) | 2.28665994 |
107 | Limb dystonia (HP:0002451) | 2.27916002 |
108 | Abnormality of proline metabolism (HP:0010907) | 2.27603940 |
109 | Hydroxyprolinuria (HP:0003080) | 2.27603940 |
110 | Neonatal onset (HP:0003623) | 2.25545725 |
111 | Glomerulonephritis (HP:0000099) | 2.25522638 |
112 | Irritability (HP:0000737) | 2.23044315 |
113 | Severe muscular hypotonia (HP:0006829) | 2.21846628 |
114 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.20916437 |
115 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.20916437 |
116 | Proximal tubulopathy (HP:0000114) | 2.20864175 |
117 | Congenital hepatic fibrosis (HP:0002612) | 2.19011736 |
118 | Vomiting (HP:0002013) | 2.18844741 |
119 | Abnormal gallbladder morphology (HP:0012437) | 2.17363335 |
120 | Abnormal cartilage morphology (HP:0002763) | 2.16265708 |
121 | Sensorimotor neuropathy (HP:0007141) | 2.14928963 |
122 | Clumsiness (HP:0002312) | 2.14034087 |
123 | Cholelithiasis (HP:0001081) | 2.12778536 |
124 | Short hallux (HP:0010109) | 2.12477772 |
125 | Cerebral edema (HP:0002181) | 2.11110513 |
126 | Hypoglycemic seizures (HP:0002173) | 2.10298260 |
127 | Progressive inability to walk (HP:0002505) | 2.10287541 |
128 | Thrombophlebitis (HP:0004418) | 2.10061103 |
129 | Polyuria (HP:0000103) | 2.10018701 |
130 | Tubulointerstitial abnormality (HP:0001969) | 2.09849709 |
131 | Sclerocornea (HP:0000647) | 2.08719895 |
132 | Enlarged kidneys (HP:0000105) | 2.08690940 |
133 | Spontaneous hematomas (HP:0007420) | 2.08132464 |
134 | Furrowed tongue (HP:0000221) | 2.07718173 |
135 | Prolonged QT interval (HP:0001657) | 2.07470108 |
136 | Progressive cerebellar ataxia (HP:0002073) | 2.07069453 |
137 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.06695714 |
138 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.06303192 |
139 | Rickets (HP:0002748) | 2.06226498 |
140 | Abnormality of the renal collecting system (HP:0004742) | 2.06105044 |
141 | Genetic anticipation (HP:0003743) | 2.04930188 |
142 | Abnormality of the pons (HP:0007361) | 2.04607319 |
143 | Cerebral hemorrhage (HP:0001342) | 2.02371247 |
144 | Late onset (HP:0003584) | 2.00505635 |
145 | Stage 5 chronic kidney disease (HP:0003774) | 1.99094844 |
146 | Chorioretinal atrophy (HP:0000533) | 1.98502413 |
147 | Conjunctival telangiectasia (HP:0000524) | 1.98112214 |
148 | Pancreatitis (HP:0001733) | 1.97782926 |
149 | Prominent supraorbital ridges (HP:0000336) | 1.96589785 |
150 | Abnormality of the gallbladder (HP:0005264) | 1.96178975 |
151 | Respiratory distress (HP:0002098) | 1.94608546 |
152 | Gaze-evoked nystagmus (HP:0000640) | 1.94290024 |
153 | Nephritis (HP:0000123) | 1.93673154 |
154 | Stomach cancer (HP:0012126) | 1.93512129 |
155 | Abnormality of renin-angiotensin system (HP:0000847) | 1.93369200 |
156 | Menorrhagia (HP:0000132) | 1.93166652 |
157 | Tachypnea (HP:0002789) | 1.93110471 |
158 | Genital tract atresia (HP:0001827) | 1.93011059 |
159 | Vaginal atresia (HP:0000148) | 1.93003574 |
160 | Lissencephaly (HP:0001339) | 1.92826558 |
161 | Hemorrhage of the eye (HP:0011885) | 1.92755756 |
162 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.92508365 |
163 | Duplicated collecting system (HP:0000081) | 1.92216155 |
164 | Gait imbalance (HP:0002141) | 1.92018297 |
165 | Calf muscle hypertrophy (HP:0008981) | 1.91768738 |
166 | Broad-based gait (HP:0002136) | 1.90999169 |
167 | Acanthocytosis (HP:0001927) | 1.90933977 |
168 | Nephrolithiasis (HP:0000787) | 1.89818364 |
169 | Renal cortical cysts (HP:0000803) | 1.89323011 |
170 | Facial shape deformation (HP:0011334) | 1.88968966 |
171 | Potter facies (HP:0002009) | 1.88968966 |
172 | Short tibia (HP:0005736) | 1.88819903 |
173 | Male pseudohermaphroditism (HP:0000037) | 1.88278301 |
174 | Interstitial pulmonary disease (HP:0006530) | 1.88171205 |
175 | Stroke (HP:0001297) | 1.86767298 |
176 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.84305911 |
177 | Hypoplasia of the pons (HP:0012110) | 1.84042422 |
178 | Bile duct proliferation (HP:0001408) | 1.83652772 |
179 | Abnormal biliary tract physiology (HP:0012439) | 1.83652772 |
180 | Abnormal urine output (HP:0012590) | 1.82144286 |
181 | Conical tooth (HP:0000698) | 1.81656416 |
182 | Decreased central vision (HP:0007663) | 1.80779974 |
183 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.79314601 |
184 | Concave nail (HP:0001598) | 1.79258732 |
185 | Exertional dyspnea (HP:0002875) | 1.78641843 |
186 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.78122439 |
187 | Anencephaly (HP:0002323) | 1.77871559 |
188 | Hemiparesis (HP:0001269) | 1.75445516 |
189 | Pachygyria (HP:0001302) | 1.74706648 |
190 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.73931142 |
191 | Congenital primary aphakia (HP:0007707) | 1.73861523 |
192 | Protruding tongue (HP:0010808) | 1.73243195 |
193 | Polyphagia (HP:0002591) | 1.72521475 |
194 | Broad metatarsal (HP:0001783) | 1.72090343 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.67149323 |
2 | TIE1 | 4.64444344 |
3 | FGFR4 | 4.18965717 |
4 | ERN1 | 3.80906426 |
5 | ADRBK2 | 3.59455515 |
6 | SIK1 | 3.41754912 |
7 | BMPR1B | 3.10463124 |
8 | TLK1 | 2.88310567 |
9 | TGFBR2 | 2.75106843 |
10 | ACVR1B | 2.68747175 |
11 | ZAK | 2.46588016 |
12 | TRIB3 | 2.31172445 |
13 | TAOK3 | 2.09377340 |
14 | MST1R | 2.06650300 |
15 | INSRR | 2.03122305 |
16 | ERBB4 | 1.89118601 |
17 | MAP4K2 | 1.87037790 |
18 | PKN2 | 1.86838232 |
19 | MAPK13 | 1.75033442 |
20 | MUSK | 1.68590191 |
21 | FGFR2 | 1.68031823 |
22 | PTK6 | 1.60746237 |
23 | ADRBK1 | 1.58726062 |
24 | CASK | 1.58647536 |
25 | DAPK2 | 1.57431019 |
26 | KDR | 1.54748787 |
27 | MAP2K4 | 1.54040763 |
28 | MAP3K4 | 1.53804167 |
29 | TYK2 | 1.48709560 |
30 | EPHB1 | 1.45645430 |
31 | GRK1 | 1.42854560 |
32 | MARK1 | 1.39801817 |
33 | PNCK | 1.37743530 |
34 | LATS1 | 1.37355006 |
35 | OBSCN | 1.36295464 |
36 | MAPK11 | 1.35531784 |
37 | MYLK | 1.33094596 |
38 | PHKG2 | 1.32235667 |
39 | PHKG1 | 1.32235667 |
40 | MAP3K3 | 1.32143951 |
41 | NUAK1 | 1.29255813 |
42 | NEK9 | 1.28202623 |
43 | MAP2K3 | 1.28202147 |
44 | CSK | 1.26426595 |
45 | MAPKAPK3 | 1.22727710 |
46 | ABL2 | 1.22510144 |
47 | WNK4 | 1.22343627 |
48 | RIPK1 | 1.21627054 |
49 | EPHB2 | 1.17710094 |
50 | FLT3 | 1.16971687 |
51 | STK38L | 1.16265699 |
52 | LRRK2 | 1.14971787 |
53 | PRKCE | 1.14053189 |
54 | PIK3CG | 1.13248297 |
55 | TNIK | 1.11850745 |
56 | MAP3K7 | 1.11661065 |
57 | JAK2 | 1.08548055 |
58 | CAMKK2 | 1.05988567 |
59 | FRK | 1.05094769 |
60 | DYRK2 | 1.04879390 |
61 | PRKCG | 1.02679542 |
62 | JAK1 | 1.00990766 |
63 | STK39 | 1.00980751 |
64 | MAPK15 | 0.97443816 |
65 | PINK1 | 0.95710170 |
66 | MET | 0.94678129 |
67 | GRK6 | 0.94404903 |
68 | TBK1 | 0.93943149 |
69 | NLK | 0.93472840 |
70 | WNK3 | 0.92494411 |
71 | PIK3CA | 0.92305240 |
72 | RPS6KA5 | 0.91801228 |
73 | NTRK3 | 0.89496511 |
74 | PRKAA2 | 0.88891583 |
75 | GSK3A | 0.87702284 |
76 | GRK7 | 0.87228582 |
77 | VRK1 | 0.86109102 |
78 | OXSR1 | 0.82924379 |
79 | MAPKAPK5 | 0.81859661 |
80 | EPHA3 | 0.81025972 |
81 | TXK | 0.79663464 |
82 | TRPM7 | 0.79660561 |
83 | FGFR3 | 0.79606015 |
84 | FER | 0.79571699 |
85 | MAP2K7 | 0.79150949 |
86 | MAPK4 | 0.77072074 |
87 | PDPK1 | 0.76480566 |
88 | CAMK1D | 0.76351420 |
89 | PRKCZ | 0.76178788 |
90 | PDK3 | 0.74606451 |
91 | PDK4 | 0.74606451 |
92 | PDGFRA | 0.73153036 |
93 | PTK2 | 0.71408494 |
94 | CAMK2A | 0.70105489 |
95 | TGFBR1 | 0.68895333 |
96 | ERBB2 | 0.68477104 |
97 | MAPK12 | 0.65953855 |
98 | SGK3 | 0.65188211 |
99 | MAP3K14 | 0.64658829 |
100 | PKN1 | 0.63483773 |
101 | GRK5 | 0.61382242 |
102 | PRKACA | 0.60544663 |
103 | MAP2K2 | 0.60361745 |
104 | STK10 | 0.60117630 |
105 | PRKACG | 0.59785036 |
106 | MAP3K2 | 0.58140638 |
107 | MAP3K11 | 0.56990520 |
108 | SGK223 | 0.56938398 |
109 | SGK494 | 0.56938398 |
110 | NTRK2 | 0.55181616 |
111 | CDK6 | 0.55019588 |
112 | ZAP70 | 0.55006548 |
113 | CAMK2G | 0.54197009 |
114 | MKNK2 | 0.53207792 |
115 | IRAK1 | 0.52988360 |
116 | DYRK1B | 0.51543937 |
117 | EGFR | 0.50807971 |
118 | RPS6KA6 | 0.49587360 |
119 | PRKG1 | 0.49155654 |
120 | CHUK | 0.47314611 |
121 | PRKCQ | 0.47115829 |
122 | IKBKE | 0.46859518 |
123 | MAP2K6 | 0.46564338 |
124 | CSNK1G2 | 0.45326980 |
125 | IGF1R | 0.45248949 |
126 | CSNK1G1 | 0.45205557 |
127 | PTK2B | 0.45131202 |
128 | PDK2 | 0.44687194 |
129 | MAP2K1 | 0.44467007 |
130 | BRSK2 | 0.42918103 |
131 | CSF1R | 0.42873257 |
132 | CAMK1 | 0.42752080 |
133 | PRKCA | 0.42727826 |
134 | PRKAA1 | 0.42483681 |
135 | RET | 0.42318863 |
136 | PRKCH | 0.41289012 |
137 | IKBKB | 0.40593724 |
138 | PRKD1 | 0.40485899 |
139 | SGK2 | 0.39904504 |
140 | PAK4 | 0.39081404 |
141 | STK3 | 0.38776770 |
142 | PRKCI | 0.37576889 |
143 | STK11 | 0.36831127 |
144 | KIT | 0.36748384 |
145 | PDK1 | 0.34629828 |
146 | KSR2 | 0.33277103 |
147 | PRKACB | 0.32951842 |
148 | ROCK1 | 0.32699511 |
149 | PAK3 | 0.32363461 |
150 | WNK1 | 0.31524526 |
151 | TEC | 0.31271308 |
152 | AKT3 | 0.30322765 |
153 | MAP3K10 | 0.29322011 |
154 | CAMK1G | 0.28679259 |
155 | TTN | 0.28595518 |
156 | IRAK3 | 0.27729866 |
157 | ABL1 | 0.26900487 |
158 | CSNK1G3 | 0.26351827 |
159 | CAMK4 | 0.25492721 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.26663801 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.50137901 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.35410272 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.19493220 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.83519550 |
6 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.70590157 |
7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61732039 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.59314498 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.59197440 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.59175199 |
11 | Phototransduction_Homo sapiens_hsa04744 | 2.54290566 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.53725370 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.43261389 |
14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.42319024 |
15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39424774 |
16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.35150135 |
17 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.31339484 |
18 | Peroxisome_Homo sapiens_hsa04146 | 2.17447041 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08963947 |
20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.08588442 |
21 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.05942046 |
22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.05044985 |
23 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00724089 |
24 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88849478 |
25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.85259317 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84553739 |
27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81775311 |
28 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.80416108 |
29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.78096128 |
30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.76531311 |
31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.74763836 |
32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.74491752 |
33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73162270 |
34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.72654925 |
35 | Nicotine addiction_Homo sapiens_hsa05033 | 1.68184029 |
36 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.67587373 |
37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.63997050 |
38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61811993 |
39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.58524609 |
40 | Bile secretion_Homo sapiens_hsa04976 | 1.57711582 |
41 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.56043030 |
42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55585044 |
43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54654246 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.48389010 |
45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44930185 |
46 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41031987 |
47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34124281 |
48 | Parkinsons disease_Homo sapiens_hsa05012 | 1.32372945 |
49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30476658 |
50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.29599702 |
51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26283202 |
52 | Morphine addiction_Homo sapiens_hsa05032 | 1.24533544 |
53 | * Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24322732 |
54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19553316 |
55 | Taste transduction_Homo sapiens_hsa04742 | 1.17778941 |
56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.17236446 |
57 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.17216215 |
58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.16047130 |
59 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13462424 |
60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11686699 |
61 | ABC transporters_Homo sapiens_hsa02010 | 1.11156683 |
62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.10692246 |
63 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.10566833 |
64 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.08763810 |
65 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07337873 |
66 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07335701 |
67 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.06286220 |
68 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01542747 |
69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.01217022 |
70 | Circadian entrainment_Homo sapiens_hsa04713 | 0.98937314 |
71 | Insulin secretion_Homo sapiens_hsa04911 | 0.98440031 |
72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.97555843 |
73 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96579509 |
74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96000971 |
75 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91848799 |
76 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91445968 |
77 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.91443335 |
78 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87850408 |
79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87208749 |
80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86742509 |
81 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85074619 |
82 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84706553 |
83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84491117 |
84 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84016963 |
85 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.83050595 |
86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82515691 |
87 | Protein export_Homo sapiens_hsa03060 | 0.81912818 |
88 | Cocaine addiction_Homo sapiens_hsa05030 | 0.80289014 |
89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.79719261 |
90 | Lysine degradation_Homo sapiens_hsa00310 | 0.78763919 |
91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.77705961 |
92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75121601 |
93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75072519 |
94 | Asthma_Homo sapiens_hsa05310 | 0.73999830 |
95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.72283209 |
96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71400240 |
97 | Salivary secretion_Homo sapiens_hsa04970 | 0.70159182 |
98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.69659922 |
99 | Renin secretion_Homo sapiens_hsa04924 | 0.68775827 |
100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65870694 |
101 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63555966 |
102 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63443390 |
103 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59704711 |
104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56240063 |
105 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.53955859 |
106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.53830255 |
107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53528133 |
108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.51766302 |
109 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.49820774 |
110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49761737 |
111 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48645454 |
112 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48340386 |
113 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47861404 |
114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.46594977 |
115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46093578 |
116 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46029803 |
117 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.42620433 |
118 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41967493 |
119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41960438 |
120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.41758134 |
121 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.40460106 |
122 | Prion diseases_Homo sapiens_hsa05020 | 0.37129625 |
123 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27483597 |
124 | Insulin resistance_Homo sapiens_hsa04931 | 0.25612462 |
125 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24558733 |
126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22034846 |
127 | Galactose metabolism_Homo sapiens_hsa00052 | 0.15582519 |
128 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.13002034 |
129 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.09332272 |
130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.08438614 |
131 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06629343 |
132 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.06079723 |
133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04019182 |
134 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02965187 |
135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.01436844 |
136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1755852 |
137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1739635 |
138 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1715934 |
139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1678692 |
140 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1666377 |
141 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1625024 |
142 | Bladder cancer_Homo sapiens_hsa05219 | -0.1591574 |
143 | Amoebiasis_Homo sapiens_hsa05146 | -0.1279902 |
144 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1198067 |
145 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1086677 |
146 | Pertussis_Homo sapiens_hsa05133 | -0.1072389 |
147 | Hepatitis C_Homo sapiens_hsa05160 | -0.1049003 |
148 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0955152 |
149 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0700682 |
150 | Mineral absorption_Homo sapiens_hsa04978 | -0.0697874 |
151 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0608293 |
152 | Lysosome_Homo sapiens_hsa04142 | -0.0461126 |
153 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0152769 |
154 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0093138 |